Macclesfield, United Kingdom

Gilles Ouvry



 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Reims, FR (2011)
  • Cheshire, GB (2015)
  • Macclesfield, GB (2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Gilles Ouvry: Innovations in Chemical Compounds

Introduction

Gilles Ouvry is a notable inventor based in Macclesfield, GB, recognized for his contributions to the field of chemical compounds. With a total of three patents to his name, Ouvry's work has significantly advanced the understanding and application of pharmaceutical compositions aimed at treating various cell proliferative disorders.

Latest Patents

Among his latest innovations are two patents focusing on unique chemical compounds detailed by specific formulas. These inventions concern compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein R and R have various defined meanings. The patents outline not only the processes for their preparation but also pharmaceutical compositions containing these compounds and their applications in treating cell proliferative disorders.

Career Highlights

Ouvry is associated with AstraZeneca AB, a company renowned for its cutting-edge research and dedication to developing innovative medications. His role at AstraZeneca allows him to engage in transformative research that enhances therapeutic options in the pharmaceutical industry.

Collaborations

Throughout his career, Gilles Ouvry has collaborated with distinguished professionals, including Craig Steven Harris and Benedicte Delouvrie. Their teamwork exemplifies the importance of collaboration in driving innovation and achieving remarkable advancements in the field of medical research.

Conclusion

With a proven track record of impactful inventions and collaborations, Gilles Ouvry stands as a significant figure in the realm of chemical innovation. His work continues to pave the way for advancements in treating cell proliferative disorders, making a lasting impression on the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…